Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram tolerability and serotonin signaling in depressed adults aged 80 years and older
2009-016716-20Phase 4Terminated
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of citalopram in major depressive disorder (MDD), sponsored by Brighton and Sussex University Hospitals NHS Trust. Primary endpoint: Correlation between treatment response and serotonin signaling biomarkers. Started Mar 2010; status: terminated.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-016716-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016716-20.